Consensus
The community sees this as unlikely for Novo Nordisk at 34%, based on 5 forecasts. Forecasters are in moderate agreement.
Resolves YES if Novo Nordisk is up more than 36% 12 months out versus its baseline price.
Share your read on this question — the best forecasters show their work.
See the whole nvo discussion →